Optimization of surgical treatment of patients with ovarian cancer
DOI:
https://doi.org/10.11603/2414-4533.2016.3.6789Abstract
In the article the authors show their own experience with the technique of intraoperative intraperitoneal hypertermic intrapentoneal chemioperfusion (HYPEC) in patients with disseminated ovarian cancer. Based on analysis of 25 clinical cases, the authors note that the technique is innovative and effective. Having the many advantages of the method the authors found no difference in the toxicity of the drugs between traditional and advanced ovarian cancer treatment method using HYPEC. The authors consider, that hyperthermia is one of the possible mechanisms for overcoming resistance to platinum.
References
Aktyvnostʹ belka r53 u bolʹnykh rakom yaychnykov v zavysymosty ot chuvstvytelʹnosty k preparatam platyny / V. H. Dubynyna, A. Y. Rybyn, O. V. Kuznetsova, O. N. Morozyuk // Klyn. onkol. – 2015. – № 4 (20). – S. 91–94.
Onkohinekolohiya : navch. posib. / [V. H. Dubinina, A. I. Rybin, N. V. Tyuyeva, O. V. Lukʺyanchuk] ; za red. V. H. Dubininoyi. – Odesa, ONMedU, 2013. – 200 s.
Rak yaychnykov: kontseptsyya patoheneza y pryntsypy tera¬pyy / L. A. Ashrafyan, V. Y. Kyselev, E. L. Muyzhnek [y dr.] // On¬kolohyya. Zhurnal ym. P. A. Hertsena. – 2015. – T. 4, № 3. – S. 73–81.
Svyntsytskyy V. S. Seroznyy rak yaychnykov: testyrovanye mutatsyy henov BRCA1 y BRCA2 v Ukrayne / V. S. Svyntsytskyy // Evrazyyskyy onkolohycheskyy zhurnal (prylozh.). – 2015. – S. 79–82.
Khalafyan A. A. Statistica 6. Statystycheskyy analyz dannykh / A. A. Khalafyan. – M. : OOO “Bynom-Press”, 2008. – 512 s.
A metabolomic approach to identifying platinum resistance in ovarian cancer / L. M. Poisson, A. Munkarah, H. Madi [et al.] // J. Ovarian Res. – 2015. – Vol. 8 – P. 13.
Developing the World Health Organization Disability Assessment Schedule 2.0. / T. B. Ustün, S. Chatterji, N. Kos¬tanjsek [et al.] // Bull World Health Organ. – 2010. – Vol. 88(11) – P. 815–823.
Etude de la qualite de vie dans les neoplasies ovariennes: outils et enjeux / A. Bryand, Z. Hamidou, S. Paget-Bailly [et al.] // Gynecol. Obstet. Fertil. – 2015. – Vol. 43(2). – P. 151–157.
Hippisley-Cox J. Independent external validation of QCancer (Ovarian) / J. Hippisley-Cox, C. Coupland // Eur. J. Cancer Care (Engl). – 2013. – Vol. 22(4). – P. 559–560.
Pual Sugarbaker H. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery / Pual H. Sugarbaker. – The Ludann Company Grand Rapids, Michigan, USA, 1998. – 59 p.
Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions / N. G. Alkema, G. B. Wisman, A. G. van der Zee [et al.] // Drug Resist Updat. – 2016 – Vol. 24 – P. 55–69.
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative / E. Zikos, C. Coens, C. Quinten [et al.] // J. Natl. Cancer Inst. – 2015 – Vol. 108(5) – P. 39–41.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
